- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00518791
Integrated Multidisciplinary Care for Parkinson's Disease: a Controlled Trial
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
PD is a complex disorder, with motor as well as non-motor symptoms. Despite the complexity of PD, management of the disease is often 'monodisciplinary' since most patients are only treated by a neurologist. Stimulating compensatory strategies by allied health professionals might offer additional therapeutic relief, but this assumption is mainly based on theoretical arguments and expert opinion. Even less is known about the claim that a multidisciplinary team of multiple professionals active in complementary domains (e.g. physiotherapy, occupational therapy and speech therapy) is superior to management by each of these professionals alone.
This study anticipates to provide more insight in the clinical effectiveness and health care costs of multidisciplinary treatment in PD. Therefore, our multidisciplinary care concept (a comprehensive assessment by a dedicated multidisciplinary team and subsequent treatment by specifically trained health professionals) that is tailored to the patients' individual needs will be compared to usual care in terms of effectiveness and costs.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Fase 3
Kontakter og lokationer
Studiesteder
-
-
-
Almelo, Holland
- Ziekenhuis Groep Twente, Twenteborg Ziekenhuis
-
Arnhem, Holland
- Ziekenhuis Rijnstate
-
Assen, Holland
- Wilhelmina Ziekenhuis Assen
-
Hengelo, Holland
- Ziekenhuis Groep Twente, Streekziekenhuis Midden-Twente
-
Leeuwarden, Holland
- Medisch Centrum Leeuwarden
-
Nijmegen, Holland
- Canisius Wilhelmina Ziekenhuis
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patients with Idiopathic PD, diagnosed according to the Brain Bank Criteria of the UK Parkinson's Disease Society
- Regular control by the neurologist
- Living independently in the community
- Able to complete the trial questionnaires
Exclusion Criteria:
- Atypical parkinsonian syndromes
- Hoehn and Yahr stage 5
- Severe cognitive impairment (MMSE<24)
- Presence of other neurological disorders
- Severe co-morbidity (e.g. cancer)
- Planned surgical procedure for PD within the intervention period
- Patients who have already visited the Multidisciplinary Assessment Center
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Ikke-randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: I
Multidisciplinary Care
|
A comprehensive individualised assessment by a dedicated multidisciplinary team (Multidisciplinary Assessment Center) and subsequent treatment by specifically trained health professionals (ParkinsonNet).
|
|
Andet: II
Usual Care
|
No altered organisation of care
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Parkinson's Disease Quality of Life Questionnaire (PDQL)
Tidsramme: 8 months
|
8 months
|
|
AMC Linear Disability Score (ALDS)
Tidsramme: 8 months
|
8 months
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
SF-36 (secundary;utility score)
Tidsramme: 8 months
|
8 months
|
|
UPDRS Motor Examination (part III)(secondary)
Tidsramme: 4 months
|
4 months
|
|
UPDRS Complications of therapy (part IV)(tertiary)
Tidsramme: 4 months
|
4 months
|
|
SPDDS(tertiary)
Tidsramme: 8 months
|
8 months
|
|
Modified MACTAR scale(tertiary)
Tidsramme: 8 months
|
8 months
|
|
Parkinson Activity Scale(tertiary)
Tidsramme: 4 months
|
4 months
|
|
Omkostninger (sekundære)
Tidsramme: 8 måneder
|
8 måneder
|
|
Frequency of falls (tertiary)
Tidsramme: 8 months
|
8 months
|
|
Freezing of Gait Questionnaire (tertiary)
Tidsramme: 8 months
|
8 months
|
|
Falls Efficacy Scale (tertiær)
Tidsramme: 8 måneder
|
8 måneder
|
|
Non-Motor Symptom Assessment Scale and Quest for Parkinson's Disease (tertiary)
Tidsramme: 8 months (Quest) and 4 months (Scale)
|
8 months (Quest) and 4 months (Scale)
|
|
Hospital Anxiety and Depression Scale (tertiary)
Tidsramme: 8 months
|
8 months
|
|
Caregiver burden assessed with BELA-A-k (secondary), SF-36 (tertiary), and HADS (tertiary)
Tidsramme: 8 months
|
8 months
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Marten Munneke, PhD, UMC St Radboud
- Ledende efterforsker: Bastiaan R Bloem, MD, PhD, UMC St Radboud
- Ledende efterforsker: Marjolein A van der Marck, MSc, UMC St Radboud
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2010-IP5.1
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Multidisciplinary Care
-
Karolinska University HospitalPhilips Electronics Nederland B.V. acting through Philips CTO organizationAfsluttet
-
University of WashingtonPatient-Centered Outcomes Research InstituteAfsluttetPTSD | Fysisk skadeForenede Stater
-
Ospedale Generale Di Zona Moriggia-PelasciniAfsluttetParkinsons sygdom og Pisa syndromItalien
-
Xuanwu Hospital, BeijingBioray LaboratoriesIkke rekrutterer endnuMultipel sclerose | Neuromyelitis Optica Spectrum Disorders | Kronisk inflammatorisk demyeliniserende polyradiculoneuropati | Myasthenia Gravis, generaliseretKina
-
The Second Hospital of Shandong UniversityAktiv, ikke rekrutterende
-
The Second Hospital of Shandong UniversityAktiv, ikke rekrutterendeSikkerhed og effektivitet af cellulære lægemidler, objektiv responsrate for forsøgspersoner osvKina
-
Cellular Biomedicine Group Ltd.The First Affiliated Hospital with Nanjing Medical UniversityAfsluttetRefraktært diffust stort B-cellet lymfomKina
-
Zhejiang UniversityCarbiogene Therapeutics Co. Ltd.RekrutteringKlinisk forsøg med autologe GPC3 CAR-T-celler (CBG166) terapi for avanceret hepatocellulært karcinomAvanceret hepatocellulært karcinomKina
-
Nexcella Inc.Immix Biopharma, Inc.RekrutteringLet kæde (AL) amyloidoseForenede Stater
-
Second Affiliated Hospital, School of Medicine,...RekrutteringRecidiverende og refraktær B-celle lymfomKina